Quick Takeaways
- EcoR1 Capital, LLC filed SCHEDULE 13G/A for Atea Pharmaceuticals, Inc. Common Stock (AVIR).
- Disclosed ownership: 4%.
- Date of event: 31 Dec 2024.
EcoR1 Capital, LLC - 31 Dec 2024 SCHEDULE 13G/A Report for Atea Pharmaceuticals, Inc. Common Stock (AVIR)
- Filing Manager
- EcoR1 Capital, LLC
- Reporting Manager
- EcoR1 Capital, LLC
- Symbol
- AVIR
- Shares outstanding
- 83,541,325 shares
- Disclosed Ownership
- 3,341,653 shares
- Ownership
- 4%
- Form type
- SCHEDULE 13G/A
- Filing time
- 14 Feb 2025, 12:47:12 UTC
- Date of event
- 31 Dec 2024
- SEC
- View on sec.gov
Quoteable Key Fact
"EcoR1 Capital, LLC disclosed 4% ownership in Atea Pharmaceuticals, Inc. Common Stock (AVIR) on 31 Dec 2024."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 14 Feb 2025, 12:47.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Official SEC Source
Backed by Schedule 13D/13G
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original FilingReporting Managers (3)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| EcoR1 Capital, LLC | 4% | 3,341,653 | 0 | 3,341,653 | /s/ Oleg Nodelman | Manager | |
| Oleg Nodelman | 4% | 3,341,653 | 0 | 3,341,653 | /s/ Oleg Nodelman | Reporting person | |
| EcoR1 Capital Fund Qualified, L.P. | 3.7% | 3,156,745 | 0 | 3,156,745 | /s/ Oleg Nodelman | Manager of the General Partner, EcoR1 Capital, LLC |